Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate a method of using dendritic cells (a kind of
white blood cell) as a vaccine to stimulate your own immune system to react to your melanoma
cells.
Phase:
Phase 1
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania University of Pennsylvania